EFMC-ISMC 2021

XXVI EFMC International Symposium on Medicinal Chemistry

 Virtual Event    August 29-September 2, 2021

Committees


International Organising Committee

Chairman

Prof. Karl-Heinz ALTMANN

ETH Zürich, Zürich, Switzerland

Members

Prof. Marko ANDERLUH

University of Ljubljana, Ljubljana, Slovenia

Dr Yves P. AUBERSON

Novartis Institutes for Biomedical Research, Basel, Switzerland

Dr Karl-Heinz BARINGHAUS

Sanofi, Frankfurt, Germany

Dr Werngard CZECHTIZKY

AstraZeneca, Mölndal, Sweden

Prof. Beatriz DE PASCUAL-TERESA

CEU San Pablo University, Madrid, Spain

Dr Luc VAN HIJFTE

Symeres, Nijmegen, The Netherlands

Local Organising Committee

Members

Prof. Karl-Heinz ALTMANN

ETH Zürich, Zürich, Switzerland

Dr Yves P. AUBERSON

Novartis Institutes for Biomedical Research, Basel, Switzerland

Dr Fides BENFATTI

Syngenta International, Basel, Switzerland

Mr Stefan BONSELS

Basel Tourismus, Basel, Switzerland

Prof. Dennis GILLINGHAM

University of Basel, Basel, Switzerland

Prof. Christian HEINIS

Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Dr Georg JAESCHKE

F. Hoffmann-La Roche, Basel, Switzerland

Dr Gerhard MUELLER

Gotham Therapeutics GmbH, Basel, Germany

Prof. Jean-Louis REYMOND

SCS DMCCB & University of Bern, Bern, Switzerland

Prof. Leonardo SCAPOZZA

University of Geneva, Genève, Switzerland

Mr David SPICHIGER

Swiss Chemical Society, Basel, Switzerland

Dr Cornelia ZUMBRUNN

Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland

International Scientific Committee

Members

Prof. Esin AKI-YALCIN

Ankara University, Ankara, Turkey

Prof. Carolina H. ANDRADE

Federal University of Goias , Goiânia, Brazil

Prof. Jonathan BAELL

Monash University, Parkville, Australia

Prof. Ayla BALKAN

Hacettepe University, Ankara, Turkey

Dr Jonathan BENNETT

Merck Sharp & Dohme (MSD), Boston, United States

Prof. Andrzej BOJARSKI

Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland

Dr Martin BOLLI

Idorsia, Allschwil, Switzerland

Dr Nicholas CARRUTHERS

Janssen Research & Development (retired), San Diego, United States

Prof. Violetta CECCHETTI

Università di Perugia, Perugia, Italy

Dr Jacobo CRUCES

GalChimia, S.A., Touro, Spain

Dr Hans-Michael EGGENWEILER

Merck KGaA, Darmstadt, Germany

Dr Ola ENGKVIST

AstraZeneca, Mölndal, Sweden

Prof. Raphaël FREDERICK

UCLouvain, Brussels-Woluwe, Belgium

Prof. Alexander HILLISCH

Bayer, Monheim am Rhein, Germany

Prof. Jan KIHLBERG

Uppsala University, Uppsala, Sweden

Dr Christian KUTTRUFF

Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany

Prof. Thierry LANGER

University of Vienna, Vienna, Austria

Prof. Emmanuel MIKROS

University of Athens, Athens, Greece

Dr Martin MISSBACH

Novartis, Basel, Switzerland

Prof. Christa MÜLLER

University of Bonn, Bonn, Germany

Prof. Adam NELSON

University of Leeds, Leeds, United Kingdom

Dr Jean-Claude ORTUNO

INSTITUT DE RECHERCHES SERVIER, SURESNES, France

Prof. Roland PIETERS

Utrecht University, Utrecht, The Netherlands

Dr Alleyn T. PLOWRIGHT

Wren Therapeutics Ltd, Cambridge, United Kingdom

Prof. Vladimir POROIKOV

Institute of Biomedical Chemistry, Moscow, Russia

Prof. Thomas POULSEN

Aarhus University, Aarhus C, Denmark

Dr Raphaël RODRIGUEZ

Institut Curie, Paris, France

Prof. Gianluca SBARDELLA

University of Salerno, Fisciano, Italy

Dr David SPRING

University of Cambridge, Cambridge, United Kingdom

Prof. Edgars SUNA

Latvian Institute of Organic Synthesis, Riga, Latvia

Dr Atli THORARENSEN

Pfizer, New-York, United States

Prof. Tihomir TOMASIC

University of Ljubljana, Ljubljana, Slovenia

Dr Adrijana VINTER

Fidelta Ltd, Zagreb, Croatia

Prof. Nicolas WINSSINGER

University of Geneva, Geneva, Switzerland

Dr Clemens ZWERGEL

Sapienza University of Rome, Rome, Italy

Dr Andrija ŠMELCEROVIć

University of Nis, Nis, Serbia